This page lists all pharmaceutical reports related to the field of Cancer Immunotherapy. The reports include market research reports and pipeline analyses.
Displaying 51 - 100 of 159 results
- Gene Expression Profiling Markets
- Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market
- How to Conduct Clinical Trials in China
- Cancer Cell Therapy Markets
- Companion Diagnostics in Personalized Medicine and Cancer Therapy
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- The Worldwide Market for Cancer Diagnostics
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- Outsourcing in Drug Discovery
- Companion Diagnostics Markets
- Oncology Market Leaders - Analyses and Outlook, Market Report 2008-2023
- Therapeutic Monoclonal Antibodies Report 2008-2023
- Cancer Drug Resistance 2008
- GPCR Screening & Profiling Trends 2008
- Cancer Therapeutics - Market Insight and R&D Pipeline Analysis
- Top-10 Biotech Companies - Market Outlook, 2008-2023
- Protein Therapeutics Markets - Antithrombins, Cytokines, Growth Hormones, Hematopoietics, Insulin, Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments
- Two pharmaceutical reports for the price of one - End of year offer
- Protein Therapeutics Markets: Antithrombins, Cytokines, Growth Hormones, Hematopoietics, Insulin, Monoclonal Antibodies, Plasma Proteins, Vaccines
- Emerging Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis
- Womens Health 2009: Worldwide Prescription Drug Markets
- Companion Biomarkers in Drug Development
- Therapeutic Monoclonal Antibodies Markets
- New Approaches to Pharma Research and Development: Evolving strategies to rejuvenate Research and Development efficiency
- World Market for Cancer Therapeutics and Biotherapeutics
- Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
- Monoclonal Antibodies in Cancer Therapy 2009-2024
- Monoclonal Antibody Therapeutics 2009-2024
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- Global Pharmaceutical Biotech Market 2010-2025
- Lung Cancer Therapeutics Market Outlook and Pipeline Analysis
- Cancer Therapeutics: Market Insight and R&D Pipeline Analysis
- Molecular Diagnostics in Cancer Testing
- The Worldwide Market for Cancer Diagnostics - 2010
- The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
- The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
- Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
- Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
- Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape
- Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
- Biomarkers in Breast Cancer, 2010
- Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
- Oncology Market Leaders – Analyses and Outlook – 2010-2025
- Melanoma - Drug Pipeline Analysis and Market Forecasts to 2015
- Non-Small-Cell Lung Cancer (NSCLC) - Drug Pipeline Analysis and Market Forecasts to 2015
- Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015
- Prostate Cancer - Drug Pipeline Analysis and Market Forecasts to 2015
- World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)